Journal of Clinical Pathology 2008;61:355-360
ORIGINAL ARTICLES
The molecular epidemiology of influenza viruses: a lesson from a highly epidemic season
1 Department of Public Medicine Sciences, U.C.O. Hygiene and Preventive Medicine, CIRI-IV, University of Trieste and IRCCS "Burlo Garofolo", Trieste, Italy
2 Friuli-Venezia Giulia Regional Health Direction, Trieste, Italy
Professor Cesare Campello, U.C.O. Hygiene and Preventive Medicine, Department of Public Medicine Sciences, Via dellIstria 65/1, 34137 Trieste, Italy; campello{at}burlo.trieste.it
Aims: To analyse the epidemiological and molecular features of a long-lasting epidemic (12 weeks) of influenza in north-eastern Italy during the 2004–05 season.
Methods: Morbidity rates were analysed by time and age. Influenza virus isolates (93 strains) were submitted to antigenic evaluation by haemagglutination inhibition test and to molecular assessment by sequencing.
Results: The incidence peak (16.4 per thousand) was the highest recorded over the last six years in north-eastern Italy. The epidemic was sustained by two subsequent waves of circulating viruses: an H3N2 variant and two type B variants, respectively. In addition, scattered isolation of an H1N1 variant occurred. Antigenic and molecular characterisation showed the emergence of an H3N2 virus drifted with respect to vaccine strain, which also had a substantial impact on morbidity in vaccinated subjects. Moreover, a single K145N substitution in the HA1 site of H3N2 was the starting point of two evolutionary branches. No change was observed in H1N1 isolates. B-type virus was mainly represented by Victoria-lineage strains, though Yamagata-lineage viruses were also identified. The fluctuating circulation of these two clades has characterised B virus epidemics in recent years.
Conclusions: The assessment of the H3N2 molecular change in this area was in line with results used for establishing the vaccine composition for the incoming season. The particular epidemiological features of two B virus clades, namely Yamagata-like and Victoria-like, may be considered for introduction into the influenza vaccine.
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
